ProCE Banner Activity

Patient Perspective: Switching to Long-Acting Injectable ART

Clinical Thought
Learn why one patient feels that long-acting ART gave her a lot of her life back.

Released: September 16, 2021

Expiration: September 15, 2022

No longer available for credit.

Share

Faculty

Anonymous (Patient)

Anonymous (Patient)

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Anonymous (Patient),

Patient has no relevant conflicts of interest to report.